Navigation Links
DRAXIS Share Buyback Approved by TSX
Date:1/16/2008

s only as of the date made.

These statements are not guarantees of future performance. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks, uncertainties and other factors that may cause the actual results or performance of the Company to be materially different from such statements or from any future results or performance implied thereby. Factors that could cause the Company's results or performance to differ materially from a conclusion, forecast or projection in the forward-looking statements include, but are not limited to:

- the achievement of desired clinical trial results related to the

Company's pipeline products;

- timely regulatory approval of the Company's products;

- the ability to comply with regulatory requirements applicable to the

manufacture and marketing of the Company's products;

- the Company's ability to obtain and enforce effective patents;

- the non-infringement of third party patents or proprietary rights by

the Company and its products;

- factors beyond our control that could cause interruptions in our

operations in our single manufacturing facility (including, without

limitation, material equipment breakdowns);

- reimbursement policies related to health care;

- the establishment and maintenance of strategic collaborative and

commercial relationships;

- the Company's dependence on a small number of key customers;

- the disclosure of confidential information by our collaborators,

employees or consultants;

- the preservation of healthy working relationships with the Company's

union and employees;

- the Company's ability to grow the business;

- the fluctuation of our financial results and exchange and interest

rate fluctuations;

- the adaptation to changing technologies;

- the loss of ke
'/>"/>

SOURCE DRAXIS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. DRAXIS Announces Application for Normal Course Issuer Bid
2. DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
3. DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer
4. DRAXIS to Present at the 2007 UBS Global Life Sciences Conference
5. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
6. Regence Enables Members to Share Feedback With Each Other When Researching Health Care Provider Options
7. AlphaRx CEO Accumulates More Company Shares
8. Private Equitys Top Execs to Share Advice, Candid Predictions at 2008 Outlook Conference
9. HearAtLast Holdings, Inc. Provides Shareholder Update
10. QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index
11. Body Abnormalities, Childhood Cancer May Share Genes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Park, California (PRWEB) March 05, 2015 ... (JCAP) last week released a special issue ... in the field of PANDAS (Pediatric Autoimmune Neuropsychiatric ... Neuropsychiatric Syndromes), an autoimmune reaction triggered by infections ... lyme, which result in inflammation of the child's ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Think it’s tough ... even tougher to get them to brush their teeth. That’s ... parents released today by Delta Dental(1) in conjunction with National ... (45 percent) say getting kids to brush their teeth is ... to do. That’s slightly higher than getting children to eat ...
(Date:3/5/2015)... 05, 2015 Wimbledon Health Partners ... vascular, echocardiogram and NCV testing, announced the ... Chief Medical Officer. Dr. Artel will be responsible for ... the WimbledonMED program and the continued growth and support ... working with Wimbledon Health Partners as a consulting physician ...
(Date:3/5/2015)... 05, 2015 Altec Products, Inc., a ... today their participation in the Houston, TX and Charlotte, ... Inspire Tour will unite Sage enterprise resource planning (ERP) ... workable solutions to real-world business challenges. , The ... Plaza Houston Galleria Area on March 10th. The Charlotte, ...
(Date:3/5/2015)... March 5, 2015 – As National Patient ... 8-14, 2015), children’s hospitals around the country are affirming ... stays as safe as possible for their children. , ... for Patient Safety (SPS) and the Children’s Hospital Association—are ... when visiting the hospital with their child. , ...
Breaking Medicine News(10 mins):Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 3Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 3Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 2Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 3Health News:Altec Attends Sage Inspire Tour Stops in Houston and Charlotte to Showcase Sage ERP Document Management and Workflow Solution 2Health News:Altec Attends Sage Inspire Tour Stops in Houston and Charlotte to Showcase Sage ERP Document Management and Workflow Solution 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 2Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 4
... KING OF PRUSSIA, Pa., April 20 Universal Health Realty ... its Board of Trustees has appointed Randall C. Stein as ... Board of Trustees and the fifth independent Trustee. ... Realty, Inc. (since 1995), an integrated commercial real estate company ...
... Novartis) to the NCCN Guidelines for Kidney Cancer as ... whose disease has progressed after treatment with kinase inhibitors. ... 30, 2009 FDA approval of everolimus based upon results ... significantly extended progression-free survival in a specific group of ...
... Centers Improve Access; Deliver High-Quality Care with TechnologyTAMPA, ... a Health Resources and Services Administration (HRSA)-sponsored health ... of a successful collaboration among 54 community health ... Sage Intergy EHR for member community health centers ...
... screening rates but one that can be fixed, study ... doctor-patient communication and not having a regular primary-care doctor ... rates among black Americans, a new study suggests. , ... Baltimore, and found that those who,d been screened for ...
... Now Estimated to be at least $0.35 per Diluted ... Service Corporation (Nasdaq: PRSC ) today announced ... scheduled to present an overview of the Company,s operations ... April 21, 2009 at The Waldorf-Astoria Hotel in New ...
... Rita and Ike we saw a need to ... through chaos created by lack of access to ... critical care physician and CEO of PatientCentral Technologies. ... patients, their physicians, hospitals and other healthcare providers ...
Cached Medicine News:Health News:NCCN Updates Kidney Cancer Guidelines to Incorporate FDA Approval of Everolimus 2Health News:NCCN Updates Kidney Cancer Guidelines to Incorporate FDA Approval of Everolimus 3Health News:Health Choice Network Implements Sage Intergy CHC Community Health Management System and EHR Across Nation 2Health News:Health Choice Network Implements Sage Intergy CHC Community Health Management System and EHR Across Nation 3Health News:Doctor-Patient Talks Key to Blacks Getting Cancer Screens 2Health News:Providence Service Corporation to Present at the CIT 4th Annual Healthcare Conference on April 21 2Health News:Providence Service Corporation to Present at the CIT 4th Annual Healthcare Conference on April 21 3Health News:PatientCentral Technologies, LLC and VerdaSee Solutions, Inc. Team Up With Congressional Staff in Washington, DC for Disaster Preparedness 2Health News:PatientCentral Technologies, LLC and VerdaSee Solutions, Inc. Team Up With Congressional Staff in Washington, DC for Disaster Preparedness 3Health News:PatientCentral Technologies, LLC and VerdaSee Solutions, Inc. Team Up With Congressional Staff in Washington, DC for Disaster Preparedness 4
(Date:3/5/2015)...  Sanomedics, Inc. (OTC: SIMH, SIMHD) ("Sanomedics" or the ... manufacturing, and acquiring cutting-edge technology, products and services announced ... exhibiting at booth # 709 at the National ... place on March 11-13, 2015 at Caesars Palace in ... The 36 th annual NAPNAP Conference will ...
(Date:3/5/2015)... 5, 2015  Medical Diagnostic Laboratories, L.L.C., (MDL), ... complexity, state-of-the-art, automated DNA-based molecular analyses, announces that ... testing which utilizes cutting edge technology, including next- ... approximately 12,000 women are diagnosed with cervical cancer ... Genital Human Papillomaviruses (HPV) are a group of ...
(Date:3/5/2015)... 2015  Relmada Therapeutics, Inc. (OTCQB: RLMD), a ... of chronic pain, today announced the appointment of ... The panel of experts will provide support for ... advance the company pipeline of novel investigational therapies ... a range of areas including opioid receptors, addiction, ...
Breaking Medicine Technology:Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4
... Bacterin International Holdings, Inc. (NYSE Amex: ... revolutionary bone graft material and antimicrobial coatings for medical applications, ... Annual ,Best of the Uncovereds, Conference. The conference will be ... California. Bacterin,s chairman and CEO Guy Cook is ...
... Oct. 24, 2011 Reportlinker.com announces ... is available in its catalogue: ... to 2017 - Motion Preserving Spinal ... Growth http://www.reportlinker.com/p0660762/Spinal-Surgery-Devices-Market-to-2017---Motion-Preserving-Spinal-Non-Fusion-Procedures-to-Drive-Long-Term-Growth.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment ...
Cached Medicine Technology:Bacterin to Present at Sixth Annual Singular Research 'Best of the Uncovereds' Conference on October 26, 2011 2Spinal Surgery Devices Market to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth 2Spinal Surgery Devices Market to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth 3Spinal Surgery Devices Market to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth 4Spinal Surgery Devices Market to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth 5Spinal Surgery Devices Market to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth 6Spinal Surgery Devices Market to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth 7Spinal Surgery Devices Market to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth 8Spinal Surgery Devices Market to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth 9Spinal Surgery Devices Market to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth 10Spinal Surgery Devices Market to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth 11Spinal Surgery Devices Market to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth 12Spinal Surgery Devices Market to 2017 - Motion Preserving Spinal Non-Fusion Procedures to Drive Long Term Growth 13
... The Trinity Biotech Mumps IgM ... intended for the qualitative detection ... serum to Mumps for the ... performance characteristics of this kit ...
The CALBIOTECH, INC. (CBI), Mumps IgM ELISA tests system is an enzyme linked immunosorbent assay (ELISA) for the detection of IgM class antibodies to Mumps in human serum or plasma....
The DSL-05-10-MUG Mumps IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgG-class antibodies to Mumps Virus in human serum. This assay is intended for in...
... The Xact stent is self-expanding and has ... yet highly flexible mesh intended to help restore ... a smooth inner vessel surface, and potentially reduce ... diseased vessel when it is treated, which can ...
Medicine Products: